New York State Common Retirement Fund Rapt Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $73.9 Billion
- Q3 2024
A detailed history of New York State Common Retirement Fund transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 11,549 shares of RAPT stock, worth $13,858. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,549
Previous 11,549
-0.0%
Holding current value
$13,858
Previous $35,000
34.29%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RAPT
# of Institutions
105Shares Held
27.1MCall Options Held
26.7KPut Options Held
2.4K-
Vanguard Group Inc Valley Forge, PA3.16MShares$3.79 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$3.22 Million7.75% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$2.93 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$2.07 Million0.42% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$1.92 Million52.54% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $35.6M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...